PropertyValue
?:abstract
  • Coronavirus Disease 2019 (COVID-19) pandemic remains a major public health threat in most countries. The causative severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus can lead to acute respiratory distress syndrome and result in mortality in COVID-19 patients. Vitamin D is an immunomodulator hormone with established effectiveness against various upper respiratory infections. Vitamin D can stall hyper-inflammatory responses and expedite healing process of the affected areas, primarily in the lung tissue. Thus, there are ecological and mechanistic reasons to promote exploration of vitamin D action in COVID-19 patients. As no curative drugs are available currently for COVID-19, we feel that the potential of vitamin D to alter the course of disease severity needs to be investigated. Clinical studies may be undertaken to address the value of vitamin D supplementation in deficient, high-risk COVID-19 patients.
?:creator
?:doi
?:doi
  • 10.1371/journal.ppat.1008874
?:journal
  • PLoS_Pathog
?:license
  • cc-by
?:pdf_json_files
  • document_parses/pdf_json/d6ac509656c7387d3798f8e60a620cca9871a5ef.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7500624.xml.json
?:pmcid
?:pmid
?:pmid
  • 32946517.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Exploring links between vitamin D deficiency and COVID-19
?:type
?:year
  • 2020-09-18

Metadata

Anon_0  
expand all